The Clorox Company (NYSE:CLX) Holdings Lifted by Blue Trust Inc.

Blue Trust Inc. grew its position in The Clorox Company (NYSE:CLXFree Report) by 36.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,249 shares of the company’s stock after purchasing an additional 336 shares during the period. Blue Trust Inc.’s holdings in Clorox were worth $203,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Insight Folios Inc grew its position in Clorox by 3.0% in the 3rd quarter. Insight Folios Inc now owns 2,195 shares of the company’s stock worth $358,000 after purchasing an additional 63 shares during the last quarter. HCR Wealth Advisors boosted its holdings in shares of Clorox by 1.0% in the fourth quarter. HCR Wealth Advisors now owns 6,870 shares of the company’s stock valued at $1,116,000 after acquiring an additional 68 shares in the last quarter. Empower Advisory Group LLC boosted its holdings in shares of Clorox by 4.5% in the third quarter. Empower Advisory Group LLC now owns 1,823 shares of the company’s stock valued at $297,000 after acquiring an additional 78 shares in the last quarter. Aviance Capital Partners LLC boosted its holdings in shares of Clorox by 2.7% in the third quarter. Aviance Capital Partners LLC now owns 3,080 shares of the company’s stock valued at $502,000 after acquiring an additional 80 shares in the last quarter. Finally, Lindbrook Capital LLC lifted its stake in Clorox by 9.9% during the third quarter. Lindbrook Capital LLC now owns 977 shares of the company’s stock valued at $159,000 after purchasing an additional 88 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Price Performance

CLX stock opened at $150.93 on Thursday. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37. The firm has a market cap of $18.68 billion, a P/E ratio of 41.24, a P/E/G ratio of 2.53 and a beta of 0.42. The company’s 50-day moving average price is $158.38 and its two-hundred day moving average price is $159.74.

Clorox (NYSE:CLXGet Free Report) last released its earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period last year, the company posted $2.16 EPS. On average, analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

CLX has been the subject of several recent research reports. Royal Bank of Canada reissued a “sector perform” rating and set a $150.00 target price on shares of Clorox in a research note on Thursday, January 30th. Barclays upped their price target on shares of Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a research report on Wednesday, February 5th. StockNews.com downgraded shares of Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. Wells Fargo & Company raised their price target on shares of Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a report on Tuesday, February 4th. Finally, JPMorgan Chase & Co. raised their price target on shares of Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a report on Tuesday, February 4th. Four analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $158.21.

Check Out Our Latest Stock Analysis on Clorox

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Articles

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.